Center for Neuroscience Studies, Queen's University, Kingston, ON, Canada.
Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada.
Neuropsychopharmacology. 2018 Jan;43(2):285-293. doi: 10.1038/npp.2017.134. Epub 2017 Jun 26.
Chronic stress is a major cause of anxiety disorders that can be reliably modeled preclinically, providing insight into alternative therapeutic targets for this mental health illness. Neuropeptides have been targeted in the past to no avail possibly due to our lack of understanding of their role in pathological models. In this study we use a rat model of chronic stress-induced anxiety-like behaviors and hypothesized that neuropeptidergic modulation of synaptic transmission would be altered in the bed nucleus of the stria terminalis (BNST), a brain region suspected to contribute to anxiety disorders. We use brain slice neurophysiology and behavioral pharmacology to compare the role of locally released endogenous neuropeptides on synaptic transmission in the oval (ov) BNST of non-stressed (NS) or chronic unpredictably stressed (CUS) rats. We found that in NS rats, post-synaptic depolarization induced the release of vesicular neurotensin (NT) and corticotropin-releasing factor (CRF) that co-acted to increase ovBNST inhibitory synaptic transmission in 59% of recorded neurons. CUS bolstered this potentiation (100% of recorded neurons) through an enhanced contribution of NT over CRF. In contrast, locally released opioid neuropeptides decreased ovBNST excitatory synaptic transmission in all recorded neurons, regardless of stress. Consistent with CUS-induced enhanced modulatory effects of NT, blockade of ovBNST NT receptors completely abolished stress-induced anxiety-like behaviors in the elevated plus maze paradigm. The role of NT has been largely unexplored in stress and our findings highlight its potential contribution to an important behavioral consequence of chronic stress, that is, exaggerated avoidance of open space in rats.
慢性应激是焦虑障碍的一个主要原因,可以在临床前可靠地建模,为这种心理健康疾病提供替代治疗靶点的见解。过去曾针对神经肽进行过靶向治疗,但没有效果,可能是因为我们对它们在病理性模型中的作用缺乏了解。在这项研究中,我们使用了一种慢性应激诱导焦虑样行为的大鼠模型,并假设神经肽对突触传递的调制在终纹床核(BNST)中会发生改变,BNST 是一种被怀疑与焦虑障碍有关的大脑区域。我们使用脑片神经生理学和行为药理学来比较在非应激(NS)或慢性不可预测应激(CUS)大鼠的椭圆形 BNST(ovBNST)中局部释放的内源性神经肽对突触传递的作用。我们发现,在 NS 大鼠中,突触后去极化诱导囊泡神经降压素(NT)和促肾上腺皮质释放因子(CRF)的释放,共同作用增加了 ovBNST 抑制性突触传递,在记录的神经元中有 59%。CUS 通过 NT 相对于 CRF 的增强贡献增强了这种增强作用(记录的神经元中有 100%)。相比之下,无论应激如何,局部释放的阿片神经肽都会降低 ovBNST 兴奋性突触传递。所有记录的神经元中,阿片神经肽对 ovBNST 兴奋性突触传递的作用一致,与 CUS 诱导的 NT 调节作用增强一致,阻断 ovBNST NT 受体完全消除了高架十字迷宫范式中应激诱导的焦虑样行为。NT 的作用在很大程度上尚未在应激中得到探索,我们的发现强调了它对慢性应激的一个重要行为后果(即大鼠对开阔空间的过度回避)的潜在贡献。